NCT00289835View on ClinicalTrials.gov

Treatment of Moderate Vein Graft Lesions With Paclitaxel Drug Eluting Stents: The VELETI Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Coronary Artery Bypass Grafting
Interventions
DEVICE

Paclitaxel eluting stent

Patients are randomized to either stenting the moderate SVG lesion with the paclitaxel stent or standard medical treatment

Trial Locations (1)

G1V 4G5

Laval Hospital, Québec

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Laval University

OTHER